ImageneBio, Inc. (IMA)
5.75
-0.05
(-0.86%)
USD |
NASDAQ |
Dec 29, 10:43
ImageneBio Market Cap: 64.29M for Dec. 29, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| CEL-SCI Corp. | 14.99M |
| AIM ImmunoTech, Inc. | 1.009M |
| IGC Pharma, Inc. | 27.10M |
| NovaBay Pharmaceuticals, Inc. | 570.83M |
| Protalix Biotherapeutics, Inc. | 145.56M |
Market Cap Related Metrics
| Price to Book Value | 0.4598 |
| Price | 5.75 |
| Earnings Yield | -141.0% |